Literature DB >> 7834656

A novel mono-sulfated pentaglycosylceramide with the isoglobo-series core structure in rat kidney.

K Tadano-Aritomi1, M Okuda, I Ishizuka, H Kubo, P Ireland.   

Abstract

A five-sugar sulfated glycosphingolipid containing an isoglobo-series carbohydrate core was isolated from rat kidney and its structure characterized by compositional analysis, FTIR spectroscopy, methylation analysis and 1H NMR spectroscopy of the intact glycolipid and its limited degradation products, and negative liquid secondary ion mass spectrometry (LSIMS). The two dimensional chemical shift correlated spectroscopy and NOE spectroscopy provided information on the sugar sequence and linkage as well as anomeric configurations, so as to establish the presence of a 3-O-sulfated galactose and a Gal alpha 1-3Gal structure within the molecule. Negative LSIMS with collision-induced dissociation defined the sugar sequence and ceramide composition, allowing to confirm the presence, and indicating the position, of the sulfate group. The glycosphingolipid was found to be a mono-sulfated derivative of the isoglobo-series core, with the following structure: HSO3(-)-3Gal beta 1-3GalNAc beta 1-3Gal alpha 1-3Gal beta 1-4Glc beta 1-1Cer (iGb5Cer V3-sulfate).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834656     DOI: 10.1016/0008-6215(94)00208-8

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  2 in total

1.  Total syntheses of disulphated glycosphingolipid SB1a and the related monosulphated SM1a.

Authors:  Haruka Hirose; Hideki Tamai; Chao Gao; Akihiro Imamura; Hiromune Ando; Hideharu Ishida; Ten Feizi; Makoto Kiso
Journal:  Org Biomol Chem       Date:  2015-09-24       Impact factor: 3.876

2.  Structural characterization of a novel mono-sulfated gangliotriaosylceramide containing a 3-O-sulfated N-acetylgalactosamine from rat kidney.

Authors:  K Tadano-Aritomi; H Kubo; P Ireland; T Kasama; S Handa; I Ishizuka
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.